City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Marianna Koczywas, MD  
Search results:  6  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-6 Trials Jump to page:

COH Protocol Number: 14022 ClinicalTrials.gov Number: NCT02134015

Principal Investigator: Marianna Koczywas, MD
Sponsor: Industrial

Title:  Phase 3, Randomized, Placebo-Controlled, Double-blind, Multi-Center, Two-Part Study of Patritumab (U3-1287) in Combination with Erlotinib in EGFR Wild-type Subjects with Locally Advanced or Metastatic Non-Small Lung Cancer (NSCLC)Who Have Progressed on at Least One Prior Systemic Therapy

COH Protocol Number: 13382 ClinicalTrials.gov Number: NCT02031458

Principal Investigator: Marianna Koczywas, MD
Sponsor: Industrial

Title:  A Phase II, Multicenter, Single-Arm Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

COH Protocol Number: 13138 ClinicalTrials.gov Number: NCT01798485

Principal Investigator: Marianna Koczywas, MD
Sponsor: Industrial

Title:  A Randomized, Phase 3 Study of Ganetespib in Combination with Docetaxel versus Docetaxel Alone in Patients with Advanced Non-Small Cell Lung Adenocarcinoma

COH Protocol Number: 12194

Principal Investigator: Marianna Koczywas, MD
Sponsor: Cooperative Group

Title:  SWOG S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor -Induced Dermatalogic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18 (FACT-EGFR 18)Questionnaire for EGFRI-Induced Skin Toxicities

COH Protocol Number: 12089 ClinicalTrials.gov Number: NCT01654965

Principal Investigator: Marianna Koczywas, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-68, NCI #9152: A Phase I Study of ARQ 197 in Combination with IV Topotecan in Advanced Solid Tumors with an Expansion Cohort in Small Cell Lung Cancer

COH Protocol Number: 07186

Principal Investigator: Marianna Koczywas, MD
Sponsor: Institutional

Title:  Evaluation of Non Small Cell Lung Cancer (NSCLC) and Outcomes of Care

 
Results per page: 25 50 100 All 1-6 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.